Q1 2015

Filed May 6, 2015 · 10-Q · 36 days after period end · 0001615219-15-000012

Q1 2015 · 10-Q

Revenue—

Net Income

-$6.02M

no prior Q1 2014 on file

EPS Diluted

-$0.59

no prior Q1 2014 on file

Operating Cash Flow-$4,140,734—

Free Cash Flowderived-$4,167,129—

Same quarter

no prior Q1 2014 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2015 · filed May 6, 2015 · 36 d after period end

Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR